InVivo Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch NVIV and buy or sell other stocks, ETFs, and their options commission-free!About NVIV
Invivo Therapeutics Holdings Corp. operates as a research and clinical-stage biotechnology company, which engages in developing and commercializing biopolymer scaffolding devices for the treatment of spinal cord injuries. Its clinical development program is the Neuro-Spinal Scaffold implant, which is an investigational bioresorbable polymer scaffold that is designed for implantation at the site of injury within a spinal cord.
CEORichard Toselli
CEORichard Toselli
Employees6
Employees6
HeadquartersCambridge, Massachusetts
HeadquartersCambridge, Massachusetts
Founded2005
Founded2005
Employees6
Employees6
NVIV Key Statistics
Market cap79.79M
Market cap79.79M
Price-Earnings ratio—
Price-Earnings ratio—
Dividend yield—
Dividend yield—
Average volume1.40M
Average volume1.40M
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$1.74
52 Week high$1.74
52 Week low$0.1231
52 Week low$0.1231